Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMYXR.L Regulatory News (MYXR)

  • There is currently no data for MYXR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

30 Jan 2017 07:00

RNS Number : 3696V
MyCelx Technologies Corporation
30 January 2017
 

 

30 January 2017

MYCELX TECHNOLOGIES CORPORATION (AIM: MYX)

("MYCELX" or the "Company")

Trading Update

MYCELX Technologies Corporation (AIM: MYX), the provider of patented water treatment solutions for the oil and gas and commercial industrial markets worldwide, is pleased to provide a Trading Update.

Throughout 2016, MYCELX continued to demonstrate good operational progress with a recent contract award for a fifth installation of offshore water treatment equipment for a current customer. Additionally, MYCELX commissioned its fourth water treatment system servicing terminals on the Houston Ship Channel and expects the subsequent media sales to begin in 2017.

 

The Board is confident that it will be able to report results for the full year ended 31 December 2016 which are in line with market expectations, and show MYCELX having successfully achieved an operationally cash flow neutral position, in line with its stated target.

 

Since announcing its exclusive marketing and distribution agreement with Schlumberger in June 2016, both companies have collaborated to organize the global marketing initiative that was launched in 4Q 2016 and has been presented in six countries to date. This targeted engagement with industry decision makers is expected to lead to the deployment of MYCELX proprietary water treatment systems, in particular MYCELX's RE-GEN product for the upstream market. Whilst it is too early to forecast the likely 2017 revenue contribution, the pipeline is growing and joint proposal activity is increasing.

 

Overall, the MYCELX contracted order book is stronger than this time last year and the Company therefore envisages a year-on-year revenue increase for 2017 in the range of 30%, with the aim of being EBITDA neutral, and with no material change in cash balance. MYCELX's revenue is already being generated from a broader geographic base than previously. The Company fully expects this positive trend, which is a result of our deliberate efforts to broaden our geographic exposure, to continue.

 

As is widely reported, the investment climate remains uncertain and, consequently, forecasting with any degree of accuracy remains challenging. As such, we will continue to adopt a prudent approach to expenditure, whilst continuing the encouraging international sales and marketing efforts.

 

MYCELX will be providing further guidance at the time of its results for the year ended 31 December 2016, expected to be announced in May 2017.

 

 

Commenting on today's Trading Update, Connie Mixon, CEO, said:

 

"MYCELX's world leading clean water technology solutions continue to gain traction into its core market of the oil & gas sector, and increasingly beyond. Our partnership with Schlumberger is progressing well with the global marketing initiative currently underway. We are also pleased to update on other important operational milestones, such as our further work with a repeat global oil and gas customer. Our progress as a business is firmly underpinned by industry's requirement for innovative technologies to manage their water requirements. We are providing a service that not only significantly enhances the economics of our clients' projects, but that also ensures improved operational efficiencies and performance."

 

"We are pleased to confirm that we will meet guidance for 2016. Looking ahead, this year is expected to continue to show an improved financial performance. However, market uncertainty remains the reality and accurate 2017 full year guidance remains difficult at this stage. That said, we are encouraged by the levels of interest and that the order book is currently ahead of where it was at the same time last year."

 

For further information please contact: 

MYCELX Technologies Corporation

Connie Mixon, CEO

Kim Slayton, CFO

 

Tel: +1 888 306 6843

Cantor Fitzgerald Europe - Nomad and Broker

Andrew Craig

Richard Salmond

 

Tel: +44 20 7894 7000

Celicourt Communications

 Mark Antelme

Joanna Boon

 

Tel: +44 20 7520 9266

 

Certain information contained in this announcement would have constituted inside information (as defined by Article 7 of Regulation (EU) No 596/2014) prior to its release as part of this announcement.

Notes to Editors

MYCELX is a revolutionary oil-free water technology company solving the world's toughest oil removal problems in the oil and gas industry. The systems are based upon scientific breakthrough for a completely different approach to permanent oil removal. The Company created the patented MYCELX polymer using innovative molecular cohesion for removing oil from water far beyond what conventional systems have ever achieved. MYCELX systems remove oil to critically low levels in a much smaller physical footprint than conventional systems and in a virtually fail-safe process.

www.mycelx.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTOKODKPBKDNDB
Date   Source Headline
26th Nov 20137:00 amRNSFast-to-market lease programme yields new leasings
30th Oct 20133:21 pmRNSDirector/PDMR Shareholding
29th Oct 20131:56 pmRNSBlocklisting Interim Review
16th Oct 20133:12 pmRNSDirector Shareholding / Warrant Exercise
3rd Oct 20137:00 amRNSInvestor Presentation
12th Sep 20137:00 amRNSHalf Year Results Statement
19th Aug 20139:06 amRNSNotice of Results
7th Aug 20139:29 amRNSBalance of respective lines of stock
10th Jun 20135:16 pmRNSChange of Main Office Address
3rd Jun 20133:19 pmRNSTotal Voting Rights
28th May 20135:02 pmRNSHolding(s) in Company
28th May 20132:54 pmRNSDirector/PDMR Shareholding
24th May 20138:52 amRNSHolding(s) in Company
14th May 20132:14 pmRNSResult of Annual Meeting
14th May 20137:00 amRNSOperational Update & Directorate Change
9th May 20137:00 amRNSExercise of Warrant
23rd Apr 201312:49 pmRNSApplication for Block Admission
19th Apr 20137:00 amRNSAnnual Financial Report/Directorate Change
15th Apr 20132:18 pmRNSHolding(s) in Company
26th Mar 20135:21 pmRNSHolding(s) in Company
13th Mar 20137:00 amRNS2012 Preliminary Results
18th Feb 201312:09 pmRNSTransfer of MyCelx Shares between lines of stock
3rd Jan 20137:00 amRNSIssue of Equity/Total Voting Rights
12th Nov 20129:52 amRNSTransfer of MyCelx Shares between lines of stock
8th Oct 20124:11 pmRNSTransfer of MyCelx Shares between lines of stock
13th Sep 20127:00 amRNSAppointment of CFO and Board Director
30th Aug 20127:00 amRNSMyCelx Shares to be Traded on CREST
14th Aug 20127:01 amRNSWebcast interview with CEO
14th Aug 20127:00 amRNSHalf Year Results
8th Aug 20127:00 amRNSContract Win for US$2.35 Million
31st May 20127:00 amRNSRe Contract
10th May 201211:02 amRNSResult of Annual Meeting/Grant of Share Option
9th May 20127:00 amRNSTrading Statement
23rd Apr 20127:00 amRNSPurchase Orders Received for US$2.65 million
17th Apr 20125:34 pmRNSAnnual Financial Report
6th Mar 20127:00 amRNS2011 Preliminary Results
27th Feb 20127:00 amRNSNotice of Preliminary Results
9th Jan 20127:00 amRNSNon-Executive Director Appointment
21st Dec 201110:10 amRNSAccident at Gainesville R&D Site
1st Nov 201112:01 pmRNSPurchase Order Update
1st Nov 20117:00 amRNSPurchase Order and Business Update
27th Sep 20117:00 amRNSHalf Year Results Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.